ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Tongguan capsule for treating myocardial ischemia-reperfusion injury: integrating network pharmacology and mechanism study

Liu, Jiantao; Liu, Chunping; Chen, Huiqi; Cen, Huan; Yang, Hailong; Liu, Peijian; Liu, Fang; Ma, Liuling; Chen, Quanfu*; Wang, Lei*广州中医药大学
PHARMACEUTICAL BIOLOGY2023-12-31DOI: 10.1080/13880209.2023.2175877
2被引16阅读
引用收藏
分享

摘要

Context Although Tongguan capsule (TGC) is used in the treatment of coronary atherosclerotic disease, the exact mechanism remains unclear. Objective Network pharmacology and experimental validation were applied to examine the mechanism of TGC for treating myocardial ischemia-reperfusion injury (MIRI). Materials and methods The components and candidate targets were searched based on various databases such as TCMSP, TCMID, BATMAN-TCM. The binding ability was determined by molecular docking. The ischemia-reperfusion (I/R) model was constructed by ligating the left anterior descending (LAD) coronary artery. APOE(-/-) mice were divided into three groups (n = 6): Sham group, I/R group, and TGC group (1 g/kg/d). To further verification, HCAEC cells were subjected to hypoxia-reoxygenation (H/R) to establish in vitro model. Results The compounds, such as quercetin, luteolin, tanshinone IIA, kaempferol and bifendate, were obtained after screening. The affinity values of the components with GSK-3 beta, mTOR, Beclin-1, and LC3 were all In vivo, TGC improved LVEF and FS, reducing infarct size. In vitro, Hoechst 33258 staining result showed TGC inhibited apoptosis. Compare with the H/R model, TGC treatment increased the levels of GSK-3 beta, LC3, and Beclin1, while decreasing the expression of mTOR and p62 (p < 0.05). Discussion and Conclusion The findings revealed that TGC exerted a cardioprotective effect by up regulating autophagy-related proteins through the mTOR pathway, which may be a therapeutic option for MIRI. However, there are still some limitations in this research. It is necessary to search more databases to obtain information and further demonstrated through randomized controlled trials for generalization.

学科与关键词

关键词
HypoxiareoxygenationapoptosismTOR pathwaysautophagy
相关
加载中…
  • QishenYiqi dripping pill protects against myocardial ischemia/reperfusion injury via suppressing excessive autophagy and NLRP3 inflammasome based on network pharmacology and experimental pharmacology
    Li, Meng; Wang, Yueyao; Qi, Zhongwen; Yuan, Zhuo; Lv, Shichao; Zheng, Yawei; Yan, Zhipeng; Wang, Mingyang; Fu, Huanjie; Fan, Xinbiao; Ji, Nan; Liu, Ming*; Fang, Zhuyuan*Frontiers in Pharmacology, 2022, 13: 981206.被引 3
  • Integrated chemical profiling, network pharmacology and pharmacological evaluation to explore the potential mechanism of Xinbao pill against myocardial ischaemia-reperfusion injury
    Yang, Ying; Chen, Ting; Liu, Jiaming; Chen, Sixuan; Cai, Rongqing; Wu, Liqiong; Hu, Jiexiong; Lin, Qiongying; Qi, Xiaoxiao; Liu, Zhongqiu*; Cheng, Yuanyuan*PHARMACEUTICAL BIOLOGY, 2022, 60(1): 255-273.被引 5
  • Uncovering the Effect and Mechanism of Rhizoma Corydalis on Myocardial Infarction Through an Integrated Network Pharmacology Approach and Experimental Verification
    Li, Jingyan; Wu, Junxuan; Huang, Junying; Cheng, Yuanyuan; Wang, Dawei*; Liu, Zhongqiu*Frontiers in Pharmacology, 2022, 13: 927488.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
PHARMACEUTICAL BIOLOGY
发表日期
2023-12-31
卷期
第 61 卷, 第 1 期
页码
437-448
DOI
10.1080/13880209.2023.2175877
语言
ENGLISH
成果收录
SCIE

作者

  • L

    Liu, Jiantao (第一作者)

    2 · guangzhou univ chinese med

  • L

    Liu, Chunping

    2 · guangzhou univ chinese med

查看全部 10 位作者收起作者
  • C

    Chen, Huiqi

    2 · guangzhou univ chinese med

  • C

    Cen, Huan

    2 · guangzhou univ chinese med

  • Y

    Yang, Hailong

    2 · guangzhou univ chinese med

  • L

    Liu, Peijian

    guangzhou univ chinese med

  • L

    Liu, Fang

    guangzhou univ chinese med

  • M

    Ma, Liuling

    2 · guangzhou univ chinese med

  • C

    Chen, Quanfu (通讯)

    2 · guangzhou univ chinese med

  • W

    Wang, Lei (通讯)

    2 · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417